| Catalog Number |
ACMA00065265 |
| Description |
[2H4]-Taletrectinib is intended for Pharmaceuticals applications. Taletrectinib is a new-generation selective ROS1/NTRK inhibitor, orally available, that is being developed to treat people who have metastatic ROS1+ NSCLC. All information about [2H4]-Taletrectinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Molecular Weight |
409.5 |
| Molecular Formula |
C23H24FN5O |
| Purity |
≥98% |
| Isotopic Enrichment |
98% 2H |
| Stability |
≥1 year |
| Unlabeled CAS |
1505514-27-1 |
Please kindly note that our products and services are for research use only.
